Market research
NEPH Nephros Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 44M
- P/E ratio
- 25.5
- Analyst target
- 6.25
- Dividend yield
- Not available
- Beta
- 1.52
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US6406714005
- Market cap
- 44M
- P/E ratio
- 25.5
- Analyst target
- 6.25
- Dividend yield
- Not available
- Beta
- 1.52
About
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the NEPH discussion.
5 years, 4 months ago
Nephros, Inc is currently in a long term uptrend where the price is trading 13.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.
Nephros, Inc's total revenue sank by 26.2% to $2M since the same quarter in the previous year.
Its net income has dropped by 300.0% to $-820K since the same quarter in the previous year.
Finally, its free cash flow fell by 536.0% to $-2M since the same quarter in the previous year.
Based on the above factors, Nephros, Inc gets an overall score of 2/5.